Ceribell, Inc. — Investor Relations & Filings

Ceribell, Inc. is a medical technology company focused on the diagnosis and management of serious neurological conditions. The company develops and markets a point-of-care electroencephalogram (EEG) system designed for rapid deployment in critical care settings like emergency departments and intensive care units (ICUs). The system features a portable EEG headband and the AI-powered Clarity® software, which provides continuous monitoring and real-time detection of seizure activity, including non-convulsive seizures. This technology enables healthcare providers to diagnose and treat patients within minutes, aiming to improve clinical outcomes. The Clarity® seizure detection algorithm is FDA-cleared for use in both adult and neonatal patients, making it the first algorithm of its kind for newborns.